title: Selective depression of maximum rate of depolarization of guinea-pig ventricular action potentials by amiodarone and lignocaine in simulated ischaemia: comparison with encainide.
abstract: 1. Standard microelectrode techniques were used to record intracellular action potentials from guinea-pig ventricular myocardium superfused with either control physiological saline (pH 7.5; pO2 500 mmHg; [K+] 5.6 mmol/L) or 'simulated ischaemic' solution (pH 6.4; pO2 90 mmHg; [K+] 11.2 mmol/L). 2. The effects on action potential parameters of therapeutic concentrations of lignocaine, amiodarone and encainide were studied under both conditions. 3. Simulated ischaemia, in the absence of drugs, produced marked reductions in resting potential (-86.6 +/- 2.3 to -64.7 +/- 3.5 mV), maximum rate of depolarization (Vmax; 263 +/- 66 to 106 +/- 36 V/s) and action potential duration (164 +/- 24 to 97 +/- 26 ms). No drug produced any additional effect on resting potential. 4. All three drugs produced enhanced depression of Vmax in ischaemia compared to control conditions (class I effect). This was much more marked for lignocaine and amiodarone (inactivated channel blockers) than for encainide (open channel blocker). 5. In addition the prolongation of action potential duration seen with acute exposure to amiodarone (174 +/- 12 to 192 +/- 17 ms; class III effect) was abolished under simulated ischaemic conditions. 6. It is concluded that lignocaine and amiodarone exert greater selectivity for ischaemic tissue than does encainide and that amiodarone may function primarily as a class I agent under ischaemic conditions.
authors.affiliation: School of Physiology and Pharmacology, University of NSW, Kensington, Australia.
authors.forename: T J
authors.initials: TJ
authors.lastname: Campbell
authors.forename: P D
authors.initials: PD
authors.lastname: Hemsworth
mesh_terms: D000200:Action Potentials / Q000187:drug effects*; D000638:Amiodarone / Q000494:pharmacology*; D000813:Anilides / Q000494:pharmacology*; D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000494:pharmacology; D003327:Coronary Disease / Q000139:chemically induced; D016700:Encainide; D006168:Guinea Pigs; D006321:Heart / Q000187:drug effects* / Q000502:physiology*; D006352:Heart Ventricles / Q000166:cytology / Q000187:drug effects; D007700:Kinetics; D008012:Lidocaine / Q000494:pharmacology*; D009206:Myocardium / Q000166:cytology; D015222:Sodium Channels / Q000187:drug effects; D013268:Stimulation, Chemical
chemical_list: D000813:Anilides; D000889:Anti-Arrhythmia Agents; D015222:Sodium Channels; D008012:Lidocaine; D000638:Amiodarone; D016700:Encainide